Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Browse Databases and Tools

Sort by Show per page
  • Acamprosate for alcohol dependence
    Cochrane Systematic Reviews, 20-Dec-2010
  • Acetylcholinesterase inhibitors for schizophrenia
    Cochrane Systematic Reviews, 17-Oct-2012
  • Acetyl‐l‐carnitine for dementia
    Cochrane Systematic Reviews, 22-Apr-2003
  • Active placebos versus antidepressants for depression
    Cochrane Systematic Reviews, 26-Jan-2004
  • Acupuncture and related interventions for smoking cessation
    Cochrane Systematic Reviews, 23-Jan-2014
  • Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents
    Cochrane Systematic Reviews, 10-Mar-2011
  • Acupuncture for autism spectrum disorders (ASD)
    Cochrane Systematic Reviews, 7-Sep-2011
  • Acupuncture for depression
    Cochrane Systematic Reviews, 4-Mar-2018
  • Acupuncture for insomnia
    Cochrane Systematic Reviews, 12-Sep-2012
  • Acupuncture for schizophrenia
    Cochrane Systematic Reviews, 16-Oct-2014
  • Aerobic exercise to improve cognitive function in older people without known cognitive impairment
    Cochrane Systematic Reviews, 22-Apr-2015
  • Alarm interventions for nocturnal enuresis in children
    Cochrane Systematic Reviews, 4-May-2020
  • Alcohol and drug screening of occupational drivers for preventing injury
    Cochrane Systematic Reviews, 25-Jan-2009
  • Alcohol ignition interlock programmes for reducing drink driving recidivism
    Cochrane Systematic Reviews, 19-Jul-2004
  • Alcoholics Anonymous and other 12-step programmes for alcohol dependence
    Cochrane Systematic Reviews, 7-May-2009
  • Almitrine-Raubasine combination for dementia
    Cochrane Systematic Reviews, 15-Feb-2011
  • Alpha lipoic acid for dementia
    Cochrane Systematic Reviews, 26-Jan-2004
  • Alpha2‐adrenergic agonists for the management of opioid withdrawal
    Cochrane Systematic Reviews, 3-May-2016
  • Alprazolam for depression
    Cochrane Systematic Reviews, 21-May-2012
  • Alternatives to inpatient mental health care for children and young people
    Cochrane Systematic Reviews, 15-Apr-2009

Login or Subscribe


Not Yet a Subscriber?

Doctor with handheld

We offer subscriptions for individuals and institutions

To find out about all the benefits of a year-long subscription to Essential Evidence Plus, click the button below!

Learn More